Low-dose anticoagulation after isolated mechanical aortic valve replacement with Liva Nova Bicarbon prosthesis: A post hoc analysis of LOWERING-IT Trial

[1]  B. Prendergast.  Faculty of 1000 evaluation for 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2018 .

[2]  Jeroen J. Bax,et al.  Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  Y. Misawa,et al.  Fifteen-year experience with the Bicarbon heart valve prosthesis in a single center , 2015, Journal of Cardiothoracic Surgery.

[4]  A. Jaffe,et al.  A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2015 .

[5]  Uberto Bortolotti,et al.  Single center experience with the Sorin Bicarbon prosthesis: a 17-year clinical follow-up. , 2014, The Journal of thoracic and cardiovascular surgery.

[6]  Nancy M Albert,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, The Journal of thoracic and cardiovascular surgery.

[7]  Chad Hughes,et al.  Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. , 2014, The Journal of thoracic and cardiovascular surgery.

[8]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[9]  F. Laborde,et al.  The Sorin Bicarbon over 15 years clinical outcomes: multicentre experience in 1704 patients. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  C. Indolfi,et al.  LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. , 2010, American heart journal.

[11]  P. Verhamme,et al.  Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for? , 2007, European heart journal.

[12]  Y. Misawa,et al.  Clinical experience with the Bicarbon heart valve prosthesis , 2007, Journal of cardiothoracic surgery.

[13]  D. Horstkotte,et al.  Improvement of oral anticoagulation therapy by INR self-management. , 2004, The Journal of heart valve disease.

[14]  J. Ennker,et al.  INR Self-Management Permits Lower Anticoagulation Levels After Mechanical Heart Valve Replacement , 2003, Circulation.

[15]  Y. Taeymans,et al.  Lower-intensity anticoagulation for mechanical heart valves: a new concept with the ATS bileaflet aortic valve. , 2003, The Journal of heart valve disease.

[16]  G. Grunkemeier,et al.  "Our complication rates are lower than theirs": statistical critique of heart valve comparisons. , 2003, The Journal of thoracic and cardiovascular surgery.

[17]  Y. Misawa,et al.  Single-center experience with the bicarbon bileaflet prosthetic heart valve in Japan. , 2002, Artificial organs.

[18]  O. Taşdemír,et al.  Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis. , 1999, Journal of Heart Valve Disease.

[19]  J. Vandenbroucke,et al.  Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.

[20]  B. Strauer,et al.  Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. , 1994, The Journal of thoracic and cardiovascular surgery.

[21]  R. Bergemann,et al.  German experience with low intensity anticoagulation (GELIA): protocol of a multi-center randomized, prospective study with the St. Jude Medical valve. , 1993, The Journal of heart valve disease.